StonvexLoading…
StonvexStonvexStonvexCore line items from CCSI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $349.70M | $350.38M | $362.56M | $362.42M |
Operating Income | $150.24M | $149.40M | $147.23M | $151.92M |
Net Income | $84.53M | $89.44M | $77.30M | $72.71M |
EPS (Diluted) | $4.35 | $4.62 | $3.94 | $3.64 |
Total Assets | $663.82M | $602.20M | $647.25M | $633.90M |
Total Liabilities | $650.04M | $681.66M | $823.38M | $889.16M |
Cash & Equivalents | $74.69M | $33.55M | $88.72M | $94.16M |
Free Cash Flow OCF − CapEx | $105.85M | $88.31M | $77.65M | $53.10M |
Shares Outstanding | 18.96M | 19.52M | 19.25M | 19.92M |